(Q39013230)

8 September 2017

1 reference

title

Mechanisms of obesity in Prader-Willi syndrome (English)

1 reference

8 September 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M J Khan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

K Gerasimidis

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M G Shaikh

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

10 November 2016

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

3-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

cites work

Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Nutritional phases in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Prader-Willi syndrome: causes of death in an international series of 27 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Elevated plasma ghrelin levels in Prader–Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Ghrelin levels in young children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Ghrelin-induced adiposity is independent of orexigenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Prader-Willi syndrome: current understanding of cause and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Prader-Willi syndrome and growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Nutrient intake and body composition variables in Prader-Willi syndrome--effect of growth hormone supplementation and genetic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Increased Leptin Messenger RNA and Serum Leptin Levels in Children with Prader-Willi Syndrome and Nonsyndromal Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

The gut hormone peptide YY regulates appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

The hypothalamus, hormones, and hunger: alterations in human obesity and illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Nutritient intake of young children with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Impact of molecular mechanisms, including deletion size, on Prader-Willi syndrome phenotype: study of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Molecular breakpoint cloning and gene expression studies of a novel translocation t(4;15)(q27;q11.2) associated with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Paternally inherited microdeletion at 15q11.2 confirms a significant role for the SNORD116 C/D box snoRNA cluster in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Unraveling the genetics of human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJPO.12177

21 January 2018

Identifiers

DOI

10.1111/IJPO.12177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27863129%20AND%20SRC:MED&resulttype=core&format=json